Clinical trial

24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG

NCT00757835

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention treatment with latanoprost/timolol fixed combination Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention latanoprost/timolol fixed combination drops Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-05-01

PhasePHASE4

Conditions

Glaucomaverified · MONDO: glaucoma

Interventions

treatment with latanoprost/timolol fixed combinationDRUG

latanoprost/timolol fixed combination dropsDRUG

Sponsors & collaborators

Aristotle University Of Thessalonikilead sponsor

Alcon Researchcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00757835 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.